About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 1NCT01996072

EC17 for Intraoperative Imaging for Parathyroidectomy

Primary hyperparathyroidism is a significant medical and public health problem in the world and affects approximately 100,000 new patients in the United States alone. If left untreated this can lead t...

Lead sponsor: University of Pennsylvania•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Pennsylvania

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Adult patients over 18 years of age
•2. Patients presenting with primary hyperparathyroidism presumed to be resectable on pre-operative assessment
•3. Good operative candidate
•4. Subject capable of giving informed consent and participating in the process of consent.

Exclusion Criteria

•1. Pregnant women as determined by urinary or serum beta hCG within 72 hours of surgery
•2. Patients with a history of anaphylactic reactions to Folate-FITC or insects
•3. Vulnerable patient populations
•1. Homeless patients
•2. Patients with drug or alcohol dependence
•3. Children and neonates
•4. Patients unable to participate in the consent process

Related studies

Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors

NCT03039439 · Parathyroid Gland Adenoma, Parathyroid Gland Atypical Adenoma, and more

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

NCT06523582 · Neuroendocrine Neoplasm, Neuroendocrine Neoplasm of Gastrointestinal Tract, and more

Active Not Recruiting

Glycemic Control, Type II Diabetes, Parathyroidectomy

NCT05761743 · Primary Hyperparathyroidism, Type 2 Diabetes

Surgery for Primary Hyperparathyroidism (pHPT) in Patients Older Than 65 Years Compared With Follow-up

NCT01087619 · Primary Hyperparathyroidism

Not Yet RecruitingPhase 2/3

Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors

NCT07444723 · Primary Hyperparathyroidism, Parathyroid Cancer, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 3, 2018Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment10

Start dateNov 2013

Last updatedJul 3, 2018

Condition

Primary Hyperparathyroidism

Locations shown

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 3, 2018Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions